We suggest that the chronic depletion of c-Myc, brought about by salicylate-dependent AMPK activation, could account for the chemopreventive effect of aspirin on colorectal cancer, indicating a possible way forward for the therapeutic targeting of oncogenic Myc. The gene discussed is PRKAA1; the disease is colorectal cancer.